Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **ocular surface and tear film components** together form a complex anatomical and functional unit, including the corneal and conjunctival epithelium, meibomian and lacrimal glands, and the tears themselves[1][4]. The tear film is composed of an outer lipid layer (from meibomian glands), a central aqueous layer (from lacrimal glands), and an inner mucin layer (from conjunctival goblet cells), each conferring specific protective, lubricative, immune, and optical properties[1][2][3][5][6]. The integrity and stability of this unit are essential for vision, ocular comfort, and defense against pathogens, with dysfunction resulting in diseases such as dry eye, inflammation, and increased risk for infection[2][4][5][6].
Immunomodulation (e.g., cyclosporine inhibits inflammatory cytokine production in lacrimal glands and ocular surface) Lubrication/replacement of deficient tear components (artificial tears supplement aqueous/mucin/lipid) Lymphocyte function antagonist (lifitegrast blocks specific inflammation pathways in dry eye)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ocular Surface and Tear Film Components.